PHO1 Antibody in Plant Biology
PHO1 (AT3G23430) is an Arabidopsis thaliana protein involved in phosphate (Pi) transport and homeostasis.
H7 Influenza Antibodies
H7 antibodies target hemagglutinin (HA) of H7N9/H7-subtype avian influenza viruses, which pose pandemic risks.
Key Antigenic Sites on H7 HA:
-
Head Domain:
-
Site A/B: Receptor-binding site (RBS) targeted by neutralizing antibodies (e.g., H7.167) .
-
Trimer Interface (TI): Targeted by non-neutralizing but protective antibodies (e.g., H7-200) .
-
Stem Domain: Recognized by broadly reactive antibodies (e.g., MEDI8852) .
Functional Antibody Classes:
| Antibody | Target Site | Neutralizing? | Cross-Reactivity | Protective In Vivo? |
|---|
| H7.HK2 | β14 surface (HA1) | Yes | Pan-H7, some H15 | Yes (EC50: 0.3 μg/mL) |
| H7-200 | TI-II (HA1) | No | Broad H7 strains | Yes (100% survival) |
| FluA-137 | Stem (HA2) | No | Group 1 (H1, H5, H9) | Requires Fc engineering |
Mechanisms of Action:
-
Neutralizing Antibodies (e.g., H7.HK2): Block viral entry by disrupting HA-sialic acid interactions .
-
Non-neutralizing Antibodies (e.g., H7-200): Disrupt HA trimers or enhance Fc-mediated immunity .
Research Advancements in H7 Antibodies
Diagnostic and Therapeutic Applications
-
ELISA Platforms: H7-specific monoclonal antibodies (e.g., MAb 3, MAb 7) enable sensitive detection of H7 antigens (LoD: 1.6 μg/mL) .
-
Combination Therapies: Pairing neutralizing (H7.HK2) and non-neutralizing (H7.HK4) antibodies enhances protection in preclinical models .